CARLSON DNA Sequencing
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541380 Testing Laboratories and Services
- Points of contact
-
- Joshua Holliday joshua.holliday@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services Food and Drug Administration (FDA) is forecasting a new requirement for CARLSON DNA Sequencing, specifically a microbiome sequencing service. The estimated solicitation release date is December 1, 2025, with an anticipated contract award projected for February 1, 2026. This procurement falls under the Testing Laboratories and Services NAICS code 541380, indicating a technical and specialized service requirement.
While specific award values and budget ranges are not currently available, the contract involves microbiome sequencing services to be performed by a qualified testing laboratory. The primary point of contact for this opportunity is Joshua Holliday, who can be reached at joshua.holliday@fda.hhs.gov within the FDA organization. No additional information has been provided regarding the place of performance, service quantities, or precise contract scope beyond the microbiome sequencing service description.
Forecast text
CARLSON DNA Sequencing. Microbiome sequencing service.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast